Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 3
2005 1
2006 1
2007 1
2010 1
2011 1
2014 2
2015 1
2016 1
2017 2
2018 1
2019 3
2020 3
2021 4
2022 5
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Pembrolizumab in Patients With Variant Urothelial Carcinoma: A Multicenter Retrospective Study.
Minato A, Furubayashi N, Harada M, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Tamura S, Kuroiwa K, Seki N, Tomisaki I, Harada K, Nakamura M, Fujimoto N. Minato A, et al. Among authors: sakamoto n. Clin Genitourin Cancer. 2022 Oct;20(5):499.e1-499.e8. doi: 10.1016/j.clgc.2022.05.001. Epub 2022 May 5. Clin Genitourin Cancer. 2022. PMID: 35624001
Serum IgG4 Concentration Is a Potential Predictive Biomarker in Glucocorticoid Treatment for Idiopathic Retroperitoneal Fibrosis.
Mukai S, Sakamoto N, Kakinoki H, Shibuya T, Moriya R, Nishihara K, Noguchi M, Shin T, Fujimoto N, Igawa T, Ishii T, Haga N, Enokida H, Eto M, Kamba T, Sakai H, Saito S, Terada N, Kamoto T. Mukai S, et al. Among authors: sakamoto n. J Clin Med. 2022 Jun 20;11(12):3538. doi: 10.3390/jcm11123538. J Clin Med. 2022. PMID: 35743608 Free PMC article.
External Validation of a Prognostic Model Predicting Metastatic Castration-Resistant Prostate Cancer Survival in Patients Receiving Post-Docetaxel Second-Line Chemotherapy.
Blas L, Shiota M, Nakamura M, Yokomizo A, Tomoda T, Sakamoto N, Seki N, Hasegawa S, Yunoki T, Harano M, Kuroiwa K, Eto M. Blas L, et al. Among authors: sakamoto n. JMA J. 2022 Apr 15;5(2):224-229. doi: 10.31662/jmaj.2021-0198. Epub 2022 Mar 4. JMA J. 2022. PMID: 35611227 Free PMC article.
Early Phase Persistent Changes in the White Blood Cell Fraction in Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab: A Multicenter Retrospective Study.
Furubayashi N, Minato A, Negishi T, Sakamoto N, Song Y, Hori Y, Tomoda T, Masaoka H, Harada M, Tamura S, Kobayashi H, Morihara K, Kuroiwa K, Seki N, Fujimoto N, Nakamura M. Furubayashi N, et al. Among authors: sakamoto n. Anticancer Res. 2023 Oct;43(10):4701-4708. doi: 10.21873/anticanres.16666. Anticancer Res. 2023. PMID: 37772560
32 results